Ideaya and Biocytogen ink $400M+ deal; Daiichi spends more on superstar ADCs
Plus, news about PepGen, Lilly, Abcellera, CastleVax and Tracon:
Ideaya and Biocytogen ink deal worth $400M+: At the center of the deal is a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
